Results 121 to 130 of about 241,963 (315)

A Randomized, Placebo‐Controlled Trial of Hydroxychloroquine in Incomplete Lupus

Arthritis &Rheumatology, EarlyView.
Objective Patients with features of systemic lupus erythematosus (SLE) who do not fulfill classification criteria can be designated as incomplete lupus erythematosus (ILE). This condition includes individuals with a high risk of progression to SLE. Treatment of ILE may reduce symptoms, severity, and incidence of SLE.
Nancy J. Olsen, Duanping Liao, Judith A. James, Joel M. Guthridge, Cristina Arriens, Diane Kamen, Mariko Ishimori, Daniel J. Wallace, Christopher Striebich, Sonali Narain, Benjamin F. Chong, Fan He, Eric W. Schaefer, Vernon M. Chinchilli, David R. Karp   +14 more
wiley   +1 more source

Oral Lesion Management in Juvenile SLE with Hepatosplenomegaly

International Medical Case Reports Journal
Adrianus Surya Wira Rajasa,1 Wahyu Hidayat2 1Oral Medicine Residency Program, Faculty of Dentistry, Padjadjaran University, Bandung, Indonesia; 2Department of Oral Medicine, Faculty of Dentistry, Padjadjaran University, Bandung, IndonesiaCorrespondence ...
Rajasa ASW, Hidayat W
doaj  

Challenges in diagnosing concurrent acute leukemia in an immunosuppressed patient with systemic lupus erythematosus: A case report

Journal of Family Medicine and Primary Care
Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by damage to organs and cells, initially mediated by tissue-binding autoantibodies and immune complexes.
Shaily Agrawal, Amit K. Jangir, M Yogesh, Rohankumar Gandhi   +3 more
doaj   +1 more source

Basic properties of SLE

, 2004
SLE is a random growth process based on Loewner's equation with driving parameter a one-dimensional Brownian motion running with speed $\kappa$. This process is intimately connected with scaling limits of percolation clusters and with the outer boundary ...
Rohde, Steffen, Schramm, Oded
core  

Drag Reduction Improvement in Two Phase Flow System Using Traces of SLES Surfactant [PDF]

, 2008
Hayder A. Abdul Bari, Rosli Bin Mohd Yunus   +1 more
openalex   +1 more source

WCN23-0334 VITAMIN D LEVEL IN SLE PATIENTS WITH OR WITHOUT RENAL INVOLVEMENT AND IT’S RELATIONSHIP WITH DISEASE ACTIVITY (SLEDAI SCORE)

, 2023
FARNAZ NOBI, Mautoshi Debnath, S. Mahjabin, Tapos Biswas, Imran Ashraf, Sariha Noor Azad, M.Z. Ahmad, B. Mobashwera, Muhammad Bilal Akhtar, Rashedul Alam Emon, Md Nazmul Hasan Chowdhury, M.N. Islam, M.T. Miah   +12 more
openalex   +1 more source

Sjögren Disease—B Cells at the Brink: From Autoimmunity to Lymphomagenesis and the Rise of Novel B Cell–Targeted Therapies

Arthritis &Rheumatology, EarlyView.
Sjögren disease (SjD) is a common systemic autoimmune disorder characterized by inflammation of the exocrine glands, resulting in dryness. Patients frequently exhibit extraglandular manifestations affecting various organ systems. To date, there are no US Food and Drug Administration (FDA)‐approved disease‐modifying therapies for SjD. In this review, we
Rachael A. Gordon, Sara S. McCoy
wiley   +1 more source

AB0461 Benefits of vitamin d in sle depend on the organ system [PDF]

, 2017
Michelle Petri, LS Magder
openalex   +1 more source

Efficacy of Telitacicept in Childhood‐Onset Systemic Lupus Erythematosus: A Prospective Multicenter Cohort Study With Inverse Probability of Treatment Weighting –Adjusted Comparison to a Historical Control Group Treated With Belimumab

Arthritis &Rheumatology, EarlyView.
Objective The therapeutic effects of telitacicept combined with standard of care (SoC) in childhood‐onset systemic lupus erythematosus (cSLE) remain unclear. This study aims to evaluate its efficacy in comparison with belimumab combined with SoC.
Chong Luo, Shu Su, Jingyue Liu, Junyu Lin, Jin Song, Zongwen Chen, Yuanyuan Peng, Lijun Jiang, Meng Jia, Li Wang, Xinhui Jiang, Wei Zhang, Zanhua Rong, Bo Zhao, Yajun Wang, Xuemei Tang   +15 more
wiley   +1 more source

Pulp Cavity Calcification in SLE Patient Associated with Long-term Use of Glucocorticoids: A Case Study with Endodontic Approaches [PDF]

Shenjie Xu, Shishuo Ma, Weilian Sun
openalex   +1 more source